The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2/3 multicenter trial evaluating safety and efficacy of a new mucoadhesive gemcitabine suspension for ablation of upper tract urothelial carcinoma.
 
Marie-Pier St-Laurent
Honoraria - Bayer; EMD Serono
Consulting or Advisory Role - Abbvie; Janssen
 
Veronika Schmitt
Leadership - Sustained Therapeutics
Stock and Other Ownership Interests - Sustained Therapeutics
Research Funding - Sustained Therapeutics
Patents, Royalties, Other Intellectual Property - We have filed two patents on two technologies where I am listed as an inventor.
Travel, Accommodations, Expenses - Sustained Therapeutics
 
Martin Gleave
Stock and Other Ownership Interests - Sustained Therapeutics
Honoraria - AbCellera; Astellas Pharma; AstraZeneca; Bayer; Gandeeva; Janssen; Pfizer
Consulting or Advisory Role - AbCellera; Astellas Pharma; AstraZeneca; Bayer; Gandeeva Therapeutics; Janssen; Pfizer
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - ST-CP; ST-POP
 
Peter Black
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Combat Medical; EMD Serono; Ferring; Janssen Oncology; Merck; Nanobot; Nanobot; NanOlogy; Nonagen Bioscience; Pfizer; Photocure; Prokarium; Sumitomo Pharma Oncology; TerSera; Tolmar; Verity Pharmaceuticals
Speakers' Bureau - Bayer; Janssen Oncology; Pfizer; TerSera
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.